Aerie Pharmaceuticals

Aerie Pharmaceuticals — A to Z Product Catalog

Marketed Products (now under Alcon)

• Rhopressa® (netarsudil 0.02% ophthalmic solution)
  • Generic: Netarsudil (Rho kinase inhibitor)
  • Indication: Reduction of elevated intraocular pressure (IOP) in open-angle glaucoma or ocular hypertension
  • Dose/Form: Once-daily ophthalmic eye drop

• Rocklatan® (netarsudil 0.02% + latanoprost 0.005% ophthalmic solution)
  • Generic: Combination of netarsudil (Rho kinase inhibitor) + latanoprost (prostaglandin analogue)
  • Indication: Reduction of elevated IOP in open-angle glaucoma or ocular hypertension
  • Dose/Form: Once-daily fixed-dose combination ophthalmic eye drop

Late-Stage Investigational Product

• AR-15512
  • Generic: Cold thermoreceptor modulator (topical)
  • Indication: Dry eye disease
  • Dose/Form: Ophthalmic formulation; administered twice daily; Phase 3 clinical-stage

Earlier-Stage Pipeline Candidates

• AR-13503
  • Type: PKC × ROCK inhibitor
  • Indication: Diabetic macular edema (and explored for wet age-related macular degeneration)
  • Dose/Form: Investigational

• AR-6121
  • Type: ROCK inhibitor
  • Indication: Post-procedural ocular inflammation
  • Dose/Form: Investigational, preclinical stage

•